Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023 Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act/S.2333 - Pandemic and All-Hazards Preparedness and Response Act Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act. S.1375/H.R. 830 HELP Copays Act Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022.
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
ALANNA TEMME JOHN MCMANUS ALANNA TEMME (LD, Rep. Jon Porter) JOHN MCMANUS (Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas) ALANNA TEMME JOHN MCMANUS
LD, Rep. Jon Porter Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas